The novel approach of the medication represents a major development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide300249.tblogz.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-55286575